Literature DB >> 1959850

Predictors of one-year pretransplant survival in patients with cirrhosis.

M Oellerich1, M Burdelski, H U Lautz, L Binder, R Pichlmayr.   

Abstract

The aim of this prospective study was to examine the usefulness of flow-dependent dynamic liver function tests and conventional methods of evaluating liver function as predictors of pretransplant survival in patients with advanced cirrhosis. Patients who underwent orthotopic liver transplantation within the follow-up period of 365 days were excluded. One hundred one patients with histologically confirmed cirrhosis were studied. Fifty-eight patients had post-hepatitic cirrhosis, 13 had cryptogenic cirrhosis and 30 had biliary cirrhosis. During follow-up, 28 patients died of their liver diseases. At entry, we recorded indocyanine green half-life, monoethylglycinexylidide formation from lidocaine, bilirubin and albumin serum concentrations, activities of cholinesterase and alkaline phosphatase, prothrombin time, clinical complications of ascites and encephalopathy and the Pugh score. These variables were subjected as covariates to a stepwise survival analysis by use of the Cox proportional-hazards model. At the final step, Pugh score, monoethylglycinexylidide formation and indocyanine green half-life were found to be the only independent variables significantly related to 1-yr survival. The parallel combination of Pugh score and monoethylglycinexylidide test yielded the highest prognostic sensitivity (82%). The series approach combining either the Pugh score and indocyanine green test or the monoethylglycinexylidide and indocyanine green tests was associated with the highest specificity (96%/97%) and high predictive values of a positive result (81%/82%). These findings suggest that appropriate combinations of the studied flow-dependent dynamic liver function tests and the Pugh score could be useful in improving transplant candidate selection and the timing of transplantation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959850

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Oral or intravenous lidocaine administration to perform megx test?

Authors:  E Giannini; F Botta; P Romagnoli; R Testa
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Indocyanine green elimination test in orthotopic liver recipients.

Authors:  T Tsubono; S Todo; N Jabbour; A Mizoe; V Warty; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

Review 3.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

4.  MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.

Authors:  F Botta; E Giannini; P Romagnoli; A Fasoli; F Malfatti; B Chiarbonello; E Testa; D Risso; G Colla; R Testa
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

5.  Effects of intra-abdominal pressure on liver function assessed with the LiMON in critically ill patients.

Authors:  Mehmet Turan Inal; Dilek Memis; Y Atakan Sezer; Meltem Atalay; Abdullah Karakoc; Necdet Sut
Journal:  Can J Surg       Date:  2011-06       Impact factor: 2.089

6.  Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.

Authors:  A E Muñoz; C Miguez; M Rubio; M Bartellini; D Levi; A Podestá; V Niselman; R Terg
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 7.  Treatment of alcoholic liver disease.

Authors:  Ina Bergheim; Craig J McClain; Gavin E Arteel
Journal:  Dig Dis       Date:  2005       Impact factor: 2.404

Review 8.  The use of silymarin in the treatment of liver diseases.

Authors:  R Saller; R Meier; R Brignoli
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 9.  [Cholestasis and liver dysfunction in critical care patients].

Authors:  M Kredel; J Brederlau; N Roewer; C Wunder
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

10.  Pre- and post-transplant assessment of liver function in paediatric liver transplantation.

Authors:  M Burdelski; M Oellerich; J Düwel; H Raith; M Scheruhn; B Ringe; B Rodeck; A Latta; R Pichlmayr; J Brodehl
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.